Tailored Mediterranean Lifestyle Education in Participants With Subjective Cognitive Impairment

April 2, 2024 updated by: Jayne Woodside, PhD, Queen's University, Belfast

The Development and Pilot Testing of Tailored Mediterranean Lifestyle Education to Encourage Behaviour Change in Participants With Subjective Cognitive Impairment

It is estimated that 30% of Alzheimer's disease cases globally are associated with changeable risk factors, such as diet and physical activity. In particular, a Mediterranean diet (MD) has been associated with reduced risk of cognitive decline and improved brain function.

The investigators developed educational resources on the Mediterranean diet and lifestyle (THINK-MED) in accordance with the Medical Research Council guidance for developing and evaluating complex interventions, based on a systematic literature review and informed by qualitative work with patients with mild memory problems.The feedback gathered informed refinements and tailoring of the resource and overall MD intervention.

This study aims to evaluate feasibility of the "THINK-MED" Mediterranean lifestyle educational intervention to encourage dietary behaviour change among community-dwelling people with subjective cognitive impairment.

Study Overview

Detailed Description

This pilot RCT aims to evaluate the feasibility of a theory-based, tailored Mediterranean lifestyle education intervention (THINK-MED) to encourage behaviour change among participants who have subjective cognitive impairment.

This study will be a 6 month randomised controlled trial (RCT) with a total of 30 participants who will be randomised to 1 of 3 groups:

  1. Group 1 will receive the "THINK-MED" Mediterranean Lifestyle Education for Memory resource on one occasion at baseline (n=10)
  2. Group 2 will receive the "THINK-MED" Mediterranean Lifestyle Education for Memory resource at monthly intervals for 5 months, with an initial face-to-face visit from the research dietitian (month 1) and accompanied by telephone feedback (month 2-5) (n=10)
  3. Group 3 is a control group. Participants in this group will receive the "THINK-MED" Mediterranean Lifestyle Education for Memory resource after completing the 6 month study (n=10)

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Have subjective cognitive impairment - Montreal Cognitive Assessment (MoCA) score ≥ 26/30
  • Mediterranean diet score (MDS) ≤ 4 (Estruch et al. 2006)
  • Willing to make changes to their diet

Exclusion Criteria:

  • Diagnosis of dementia
  • MoCA score of ≤ 25/30
  • Individuals with a visual or English language impairment
  • Psychiatric problems e.g. depression
  • Significant medical comorbidity
  • Body Mass Index (BMI) ≤ 19 and ≥ 40 kg/m2
  • Excessive alcohol consumption
  • Dietary restrictions/allergies that would substantially limit ability to complete study requirements
  • Inability to provide informed consent
  • History of, or comorbid condition which may alter performance on cognitive tests e.g. stroke, head injury, Parkinson's disease, learning disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1: "THINK-MED" resource (baseline)
The "THINK-MED" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards. Participants will receive this resource on one occasion at baseline (n=10)
The "THINK-MED" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards. Participants will receive this resource on one occasion at baseline.
Experimental: Group 2: "THINK-MED" resource (staged)
This group of participants will receive the "THINK-MED" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian (n=10)
This group of participants will receive the "THINK-MED" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian
Placebo Comparator: Group 3: Control
Participants will receive the "THINK-MED" resource after their final 6 month study visit (i.e. delayed intervention) (n=10)
Participants will receive the "THINK-MED" resource after their final 6 month study visit (i.e. delayed intervention).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mediterranean Diet Score (MDS) at 6 months
Time Frame: Baseline, 6 months
Mediterranean dietary intake will be measured by a validated questionnaire with a increase in score by greater than or equal to 3 points at 6 months indicating adoption (maximum score 14)
Baseline, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anthropometric measurements
Time Frame: Baseline, 6 months
Weight and height measurements to calculate BMI
Baseline, 6 months
Muscle Strength
Time Frame: Baseline, 6 months
Measured using a grip-strength dynamometer
Baseline, 6 months
Cognitive Assessment
Time Frame: Baseline, 6 months
A comprehensive cognitive assessment will be performed, including: global cognition, motor skills, executive function episodic/visual memory, and information processing and sustained attention using a validated neuropsychological test battery (Cantab Cognitive Battery, Cambridge Cognition Ltd.)
Baseline, 6 months
Barriers to consuming a Mediterranean Diet questionnaire
Time Frame: Baseline, 6 months
Dietary behaviour change questionnaire to measure adherence to a Mediterranean diet
Baseline, 6 months
Blood Sample
Time Frame: Baseline, 6 months
A blood sample will be taken from participants to be stored for analysis of biomarkers of MD adherence and biomarkers of neurodegenerative disease risk.
Baseline, 6 months
Change in Lifestyle questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure change in lifestyle behaviours
Baseline, 6 months
Dietary Quality of Life questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure dietary quality of life
Baseline, 6 months
Mediterranean Diet Knowledge questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure participants Mediterranean diet knowledge
Baseline, 6 months
Staging Algorithm Questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure participants readiness to change their diet and lifestyle
Baseline, 6 months
Mediterranean Diet self-efficacy questionnaire
Time Frame: Baseline, 6 months
A questionnaire to measure participants self-efficacy
Baseline, 6 months
Change in Physical Activity at 6 months
Time Frame: Baseline, 6 months
Physical activity will be measured by the Recent Physical Activity Questionnaire (RPAQ)
Baseline, 6 months
Geriatric Depression Scale
Time Frame: Baseline, 6 months
Depressive symptoms will be measured by the Geriatric Depression Scale Questionnaire, with a score greater than 5 indicating depressive symptoms
Baseline, 6 months
Functional Assessment (1)
Time Frame: Baseline, 6 months
Measured by the instrumental activities of daily living questionnaire (IADL) by Lawton and Brody Measured by the instrumental activities of daily living scale (IADL) by Lawton and Brody (1969) questionnaire
Baseline, 6 months
Functional Assessment (2)
Time Frame: Baseline, 6 months
Measured by the Bristol activities of daily living (Bucks et al. 1996) questionnaire
Baseline, 6 months
4 day food diary
Time Frame: Baseline, 6 months
A food diary will be completed to assess compliance with a Mediterranean diet
Baseline, 6 months
Rand Short Form-36 HEALTH SURVEY
Time Frame: Baseline, 6 months
A questionnaire to measure participants views and beliefs on health
Baseline, 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Process Evaluation (1) - telephone contact evaluation
Time Frame: Up to 3 months post intervention
Determination individual participation and engagement with the intervention by reviewing telephone contact log record and telephone checklist evaluation
Up to 3 months post intervention
Process Evaluation (2) - study records
Time Frame: Up to 3 months post intervention
A review of study records- including attrition rates, reason for dropout
Up to 3 months post intervention
Process Evaluation (3) - structured interviews
Time Frame: Up to 3 months post intervention
Post intervention structured interviews for participant evaluation of the intervention programme and dietary educational materials
Up to 3 months post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jayne Woodside, PhD, Queen's University, Belfast

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 18, 2018

Primary Completion (Actual)

June 30, 2019

Study Completion (Actual)

June 30, 2019

Study Registration Dates

First Submitted

June 3, 2018

First Submitted That Met QC Criteria

June 14, 2018

First Posted (Actual)

June 26, 2018

Study Record Updates

Last Update Posted (Actual)

April 3, 2024

Last Update Submitted That Met QC Criteria

April 2, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 18/NI/0077

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Subjective Cognitive Impairment

Clinical Trials on "THINK-MED" resource (baseline)

Subscribe